Technical Analysis for BSEM - BioStem Technologies, Inc

Grade Last Price % Change Price Change
B 1.55 -3.73% -0.0600
BSEM closed down 3.73 percent on Tuesday, April 20, 2021, on 10 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical BSEM trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
Calm After Storm Range Contraction -3.73%
Narrow Range Bar Range Contraction -3.73%
Stochastic Reached Overbought Strength -3.73%
Wide Bands Range Expansion -3.73%
Overbought Stochastic Strength -3.73%
Older End-of-Day Signals for BSEM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


BioStem Technologies, Inc Description

At Biostem Technologies (BESM), we’re all about breakthrough anti-aging and regenerative medicine that leverages the body’s innate healing capabilities. Our mission is to discover, develop, acquire, and commercialize effective and profitable anti-aging and regenerative medicine. If it helps reverse, stop, or slow the effects of biological aging (or related acute disease) and if it can be produced, sold or licensed at a good profit, it’s “on strategy” for us, regardless of whether it’s a pharmaceutical, cellular, clinical, nutraceutical, or cosmeceutical therapy. If it’s effective and profitable, we are committed to commercializing it in whatever form and distribution channel is most appropriate. With our broad base of expertise, Biostem Technologies is uniquely positioned to capture a wide range of those revenue and intellectual property opportunities, and at the same time, mitigate much of the “evolving market” risk for our shareholders


Sector: Healthcare
Industry: Biotechnology
Keywords: Emerging Technologies Nutraceutical Regenerative Medicine Cosmeceutical Ageing Regenerative Biomedicine Life Extension Senescence Futurology Population

Is BSEM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 3.4
52 Week Low 0.01
Average Volume 2,158
200-Day Moving Average 1.3689
50-Day Moving Average 1.4874
20-Day Moving Average 1.4500
10-Day Moving Average 1.5160
Average True Range 0.1355
ADX 12.34
+DI 29.0951
-DI 27.6941
Chandelier Exit (Long, 3 ATRs ) 1.2935
Chandelier Exit (Short, 3 ATRs ) 1.4265
Upper Bollinger Band 1.6764
Lower Bollinger Band 1.2236
Percent B (%b) 0.72
BandWidth 31.2276
MACD Line 0.0298
MACD Signal Line 0.0076
MACD Histogram 0.0222
Fundamentals Value
Market Cap 5.21 Million
Num Shares 3.36 Million
EPS -0.58
Price-to-Earnings (P/E) Ratio -2.67
Price-to-Sales 519.82
Price-to-Book 0.00
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.5500
Resistance 3 (R3) 1.5500 1.5500 1.5500
Resistance 2 (R2) 1.5500 1.5500 1.5500 1.5500
Resistance 1 (R1) 1.5500 1.5500 1.5500 1.5500 1.5500
Pivot Point 1.5500 1.5500 1.5500 1.5500 1.5500
Support 1 (S1) 1.5500 1.5500 1.5500 1.5500 1.5500
Support 2 (S2) 1.5500 1.5500 1.5500 1.5500
Support 3 (S3) 1.5500 1.5500 1.5500
Support 4 (S4) 1.5500